A COMPREHENSIVE ANALYSIS OF RATIONAL AND IRRATIONAL FIXED DOSE COMBINATIONS OF ANTIBACTERIAL DRUGS AVAILABLE IN THE INDIAN MARKET

Main Article Content

Dr.Pooja Solanki Mishra
Dr.Meghna Shinde
Dr.Paroma Sinha

Keywords

FDCs, Companies, Antibiotics, Banned Drugs, Irrational

Abstract

INTRODUCTION: Fixed Dose Combinations (FDCs) are products containing two or more active ingredients used for a particular indication, in a fixed ratio of doses. Today, there is a growing concern about the burgeoning list of irrational Fixed Dose Combinations (FDCs) that have flooded the pharmaceutical market in India. Such irrational use of antibiotic FDCs can rapidly give rise to resistant strains of organisms, increasing ADRs and drug interactions which is a serious concern for the health care system. The present study is designed to fill the lacuna in the research regarding rational and irrational FDCs available in the Indian market.


OBJECTIVES:1) To analyse rational and irrational FDCs of antibacterial drugs 2) To create awareness about the extensive use of irrational FDCs among the prescribers.


METHODOLOGY: Data on FDCs available in the Indian market was collected from the Current Index of Medical Specialities (CIMS) Jan-2022[2] and Drug Today Jan-Apr-2022[3] . Their rationality was analysed based on their pharmacokinetic properties, pharmacodynamic activity, drug interactions and those listed in the WHO Essential List Of Medicines 2021[4] and National List of Essential Medicines (NLEM) 2022[5] .The number of companies producing such combinations were listed. A list of prohibited drugs which are still being circulated was also given.


RESULTS: A total of 86 combinations were listed, among which 42 combinations were rational and 44 combinations were irrational. The most common irrational FDC available is Ofloxacin+ Ornidazole, produced by 130 companies. A total of 15 FDCs were found banned but being manufactured by several companies.


CONCLUSION: Many Irrational FDCs are being supplied in the Indian market by different companies. Awareness about irrational FDCs, generated among prescribers through our study, will help to avoid the unnecessary risk of ADRs, drug resistance and financial burden on the patient. Hence, scrutiny and a strict review of regulatory framework for FDC manufacturing and marketing is needed for the betterment of patient care in the country.

Abstract 11 | pdf Downloads 4

References

1. System of preliminary scrutiny by CDSCO at the time of receipt of application for Approval of Fixed Dose Combinations (FDCs) available at
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=MzI1MQ accessed on July 2023
2. Current Index of Medical Specialities(CIMS) Jan-2022
3. Drug Today Jan-Apr-2022.
4. World Health Organization Model List of Essential Medicines – 22nd List, 2021. Geneva: World Health Organization; 2021 (WHO/MHP/HPS/EML/2021.02)
5. National List of Essential Medicines 2022 available at Final%20NLEM_2022.pdf
6. List of drugs prohibited for manufacture and sale through Gazette notifications under section 26a of drugs & cosmeticsAct 1940 by the ministry of health and family welfare
7. CDSCO GUIDELINES FOR REGULARISATION OF RATIONAL FIXED DOSE COMBINATIONS available at https://cliniexperts.com/regularization-of-rational-fixed-dose-combinations-fdc accessed on July 2023.
8. 8) Promoting rational use of medicines available at https://www.who.int/activities/promoting-rational-use-of-medicines. accessed on July 2023.
9. Sharma K, Sharma A, Singh V, Pilania D, Sharma YK. Irrational fixed dose combinations & need for intervention: understanding of dental clinicians and residents. J Clin Diagn Res. 2014;8(12):ZC49-ZC52. doi:10.7860/JCDR/2014/10273.5294
10. Gautam CS, Saha L. Fixed dose drug combinations (FDCs): rational or irrational: a view point. Br J Clin Pharmacol. 2008;65(5):795-796. doi:10.1111/j.1365-2125.2007.03089.x
11. Minnu Joseph, Amalu Rose Mathew, N. K. Meera and A. S. Reema Prescribing-trends-and-rationality-of-fixed-dose-combinations-in-a-tertiary-care-hospital-an-observational-study.Indian journal of pharmaceutical sciences. Indian J Pharm Sci 2020;82(3):542-547.
12. Paolo S Ocampo Et al Antagonism between Bacteriostatic and Bactericidal Antibiotics Is Prevalent. Antimicrobial Agents and Chemotherapy. doi.org/10.1128/AAC.02463-14
13. A Review on Fixed Dose Combinations: Irrational Drug Combinations and Patient Compliance. Suhas P. Padmane et al; International Journal of Engineering Development and Research